摘要
Ferid Murad教授是一个出色的同事和导师。我们第一次见面时,他不仅分享了一氧化氮(NO)研究未解决的困惑,也听了我关于蛋白质硝化和亚硝化的问题。这是在我们实验室在研究肿瘤细胞中的信号和基因表达时涉及蛋白质硝化,诱导型一氧化氮合酶和亚硝酸盐的生产的背景下的新的开端。针对细胞膜产生的信号的细胞骨架重构的动态变化由p21活化激酶1(PAK1)调节,p21活化激酶1通过丝氨酸65和丝氨酸128 Tubulin Cofactor B(COB)磷酸化参与微管(MT)动态。在寻找MT的生物合成抵消维护MT动态平衡的机制时,我们探索了TCoB酪氨酸残基硝化的可能性。我们发现TCoB由酪氨酸98和酪氨酸64硝化而来,硝化的TCoB抑制 TCoB的磷酸化。这表明PAK1磷酸化位点是TCoB硝化的必要因素。我们提出了一个模型,其中TCoB硝化作为一种反馈机制,以抵消PAK1信号依赖微管的动态性,从而揭示内在的调节生长因子和一氧化氮在微管的动态信号协调。此外,细胞骨架重构以及导致翻译后修饰的NO的产生是细胞过程的重要修饰物。本文讨论了我与穆拉德教授第一次见面的各项事务相互作用的发展,对NO信号途径在癌症中的作用的共同兴趣以及这些相互作用如何使我们能够连接癌症细胞中的NO Cytoskeleton信号。
关键词: 反射,一氧化氮,激酶信号,PAK1,微管,癌症,GW大学教授
Current Medicinal Chemistry
Title:Reflecting Back to Bring Nitric Oxide Research to the Laboratory
Volume: 23 Issue: 24
Author(s): Rakesh Kumar
Affiliation:
关键词: 反射,一氧化氮,激酶信号,PAK1,微管,癌症,GW大学教授
摘要: Professor Ferid Murad has been a remarkable colleague and a mentor. During our very first meeting, he not only shared unresolved puzzles in Nitric Oxide (NO) research but also listened to my questions pointing to protein nitration and nitrosylation. This was start of a new avenue in my laboratory involving protein nitration, inducible nitric oxide synthase and nitrite production in the context of signaling and gene expression in cancer cells. Dynamic changes in the cytoskeleton remodeling in response to the cell membrane generated signals are regulated by p21-activated kinase 1 (PAK1) which also feed into microtubules (MT) dynamic via phosphorylating Tubulin Cofactor B (CoB) on serine 65 and serine 128. While While searching for the mechanism through which MT biogenesis might be counteracted for the purpose of maintaining the balance in MT dynamic, we explored the possibility of nitration of tyrosine residues in TCoB. We found that TCoB is nitrated on tyrosine 64 and tyrosine 98 and that nitrated TCoB inhibits TCoB phosphorylation and that intact PAK1 phosphorylation sites are also essential for the ability of TCoB to undergo nitration. We suggested a model wherein TCoB nitration acts as a feedback mechanism to counteract PAK1- signaling dependent microtubule dynamics, and thus, revealed an inherent regulatory coordination of growth factor and nitric oxide signaling in microtubule dynamics. In addition, cytoskeleton remodeling and NO production and resulting post-translational modifications in signaling modules serve as important modifiers of cellular processes. Here, I will discuss the cascade of events leading to my first meeting with Professor Murad, the development of scientific interactions, the recognition of our overlapping scientific interests in NO Signaling in cancer cells, and how these interactions have allowed us to connect NO - Cytoskeleton Signaling in cancer cells.
Export Options
About this article
Cite this article as:
Rakesh Kumar , Reflecting Back to Bring Nitric Oxide Research to the Laboratory, Current Medicinal Chemistry 2016; 23 (24) . https://dx.doi.org/10.2174/0929867323666160812150737
DOI https://dx.doi.org/10.2174/0929867323666160812150737 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Melatonin in the Biliary Tract and Liver: Health Implications
Current Pharmaceutical Design The Role and Therapeutic Potential of Ser/Thr Phosphatase PP2A in Apoptotic Signalling Networks in Human Cancer Cells
Current Molecular Medicine Patent Selections
Recent Patents on Biotechnology Prodrugs and Endogenous Transporters: Are They Suitable Tools for Drug Targeting into the Central Nervous System?
Current Pharmaceutical Design The Synergistic Cytotoxic and Apoptotic Effect of Resveratrol and Naringenin on Y79 Retinoblastoma Cell Line
Anti-Cancer Agents in Medicinal Chemistry The Microarray Gene Profiling Analysis of Glioblastoma Cancer Cells Reveals Genes Affected by FAK Inhibitor Y15 and Combination of Y15 and Temozolomide
Anti-Cancer Agents in Medicinal Chemistry Gold Nanoparticle-Based Drug Delivery Platform for Antineoplastic Chemotherapy
Current Drug Metabolism Effect of Salinomycin on Expression Pattern of Genes Associated with Apoptosis in Endometrial Cancer Cell Line
Current Pharmaceutical Biotechnology Editorial :
Recent Patents on CNS Drug Discovery (Discontinued) Tracking Stem Cells for Cellular Therapy in Stroke
Current Pharmaceutical Design Targeting 5-Lipoxygenase for Prevention and Treatment of Cancer
Current Enzyme Inhibition Mechanisms of Drug Resistance in Cancer Chemotherapy: Coordinated Role and Regulation of Efflux Transporters and Metabolizing Enzymes
Current Pharmaceutical Design Dendritic Cell Immunotherapy for Melanoma
Reviews on Recent Clinical Trials Tumoral Drug Metabolism: Perspectives and Therapeutic Implications
Current Drug Metabolism The 1,4-Dihydropyridine Nucleus: A Pharmacophoric Template Part 1. Actions at Ion Channels
Mini-Reviews in Medicinal Chemistry Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Interleukin-24: A Molecule with Potential Anti-Cancer Activity and a Cytokine in Search of a Function
Endocrine, Metabolic & Immune Disorders - Drug Targets Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
Current Medicinal Chemistry Phosphoinositide 3-Kinases and Leukocyte Migration
Current Immunology Reviews (Discontinued) Anti-cancer Drug Discovery: Update and Comparisons in Yeast, Drosophila, and Zebrafish
Current Molecular Pharmacology